Amanda Singleton | Biopharma Partnerships
GeneDx

Amanda Singleton, Biopharma Partnerships, GeneDx

Amanda Singleton began her career in academia studying genetic causes of Parkinson disease and other movement disorders. After doing research at both Mayo Clinic and the National Institutes of Health, she become a laboratory genetic counselor at GeneDx. For the last 4 years, Amanda has been working in business development at GeneDx to forge partnerships with industry that advance the understanding of rare diseases, accelerate therapeutic development, and enable access to genetic testing. 

Appearances:



Day 2 - World Orphan Drug Congress USA 2024 @ 13:00

The role of genomic sequencing in advancing precision medicine

last published: 25/Apr/24 18:55 GMT

back to speakers

Get Involved At World Orphan Drug Congress USA

 

To Sponsor Or Exhibit

 
 

Justin Franks
justin.franks@terrapinn.com
t/ +1 914 819 3506

 

 

 

To Speak

 
 

Gina McHugh
gina.mchugh@terrapinn.com
t/ +1 646 619 1775

 

 

 

Marketing & Press Opportunities

 
 

Kaylie Brogan
kaylie.brogan@terrapinn.com